Popular Hemp

Jan 7, 2021 – Australia: Bod Australia (ASX:BDA) reported robust medicinal Cannabis sales In 2H CY2020.

Bod Australia Limited (ASX: BDA) reported strong growth in the sales for medicinal cannabis in the second half of the calendar year 2020. A total of 3,941 MediCabilis™ prescriptions were filled during the period, which represents a growth of 114% as compared to 2H CY2019 and 91% as compared to 1H CY2020.

[embedded content]

0 thoughts on “Jan 7, 2021 – Australia: Bod Australia (ASX:BDA) reported robust medicinal Cannabis sales In 2H CY2020.”

Write a Reply or Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.